Related Experiment Video
Updated: Feb 14, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
Clinico-epidemiological Profile of Pediatric Rheumatology Disorders in Eastern India
Pratap Kumar Patra1, Manish Kumar1
1Department of Pediatrics, All India Institute of Medical Sciences, Patna, Bihar, India.
Insights
Pediatric rheumatological disorders in India are distinct from Western populations, with Juvenile Idiopathic Arthritis (JIA) being most common. Limited access to biological agents impacts treatment, highlighting a need for further investigation.
Area of Science:
- Pediatric Rheumatology
- Epidemiology
- Clinical Medicine
Background:
- Limited data exists on pediatric rheumatological disorders in India.
- Understanding these conditions is crucial for developing evidence-based healthcare services.
Purpose of the Study:
- To investigate the clinical and epidemiological profile of rheumatological disorders in children in India.
- To identify common diagnoses, treatment patterns, and challenges in managing these conditions.
Main Methods:
- A retrospective hospital-based study was conducted.
- Data from January 2015 to December 2016 was analyzed.
- Included clinical, laboratory findings, and treatment responses of 60 children.
Main Results:
- Juvenile Idiopathic Arthritis (JIA) was the most frequent diagnosis, with polyarticular JIA being the predominant subtype.
- The mean age of onset was 9.1 years; Methotrexate was the most common disease-modifying antirheumatic drug.
- Financial constraints prevented the use of biological agents; 10% used alternative medicine.
Conclusions:
- The clinical and epidemiological profile of pediatric rheumatological disorders in this Indian cohort differs from Western populations.
- The lack of access to biological agents for Juvenile Idiopathic Arthritis (JIA) management warrants further consideration.
Background:
Data on rheumatological disorders in children from developing countries like India are scarce. Hence, this study aimed to understand the clinical and epidemiological profile of rheumatological disorders in children as this can help organize comprehensive evidence-based health care services.
Methodology:
A retrospective hospital-based study was designed in pediatric rheumatology clinic of the All India Institute of Medical Sciences, Patna, India, from January 2015 to December 2016. Clinical and laboratory findings and response to therapy of all children with rheumatological disorders were evaluated.
Results:
A total of 60 children with various rheumatological disorders were included in the study. Juvenile idiopathic arthritis (JIA) was the most common pediatric rheumatology disorder observed, and polyarticular JIA was the predominate subtype observed in our patients. The mean age of disease onset was 9.1 ± 3.6 years (age range: 1-16 years). Methotrexate was the most common disease modifying antirheumatic drug used. None of the children received newer biological agents due to financial constraints. The use of alternative medicine was observed in 10% of cases.
Conclusion:
The clinical and epidemiological profile of children with rheumatological disorders in our patient group was different from the European countries and Western world. There is a need for introspecting the lack of using biological agents and its potential impact in managing JIA in our patient group.
Related Concept Videos
Introduction to Epidemiology
Causality in Epidemiology
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Confounding in Epidemiological Studies
Bias in Epidemiological Studies
Intrinsically Disordered Proteins

